|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor. |
| 公司地址
| 66 Hudson Boulevard East, New York, NY, USA, 10001-2192 |
| 電話號碼
| +1 212 733-2323 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pfizer.com |
| 員工數量
| 75000 |
| Mr. David M. Denton |
Chief Financial Officer and Executive Vice President |
美元 1.39M |
18/06/2026 |
| Ms. Lidia L. Fonseca |
Executive Vice President, Chief Digital and Technology Officer |
-- |
26/02/2026 |
| Mr. Douglas M. Lankler |
Chief Legal Officer and Executive Vice President |
美元 1.41M |
26/02/2026 |
| Dr. Albert Bourla, D.V.M.,PhD |
Chairman of the Board and Chief Executive Officer |
美元 1.80M |
12/03/2026 |
| Ms. Margaret M. Madden |
Senior Vice President, Corporate Secretary and Chief Governance Counsel |
-- |
26/02/2026 |
| Ms. Jennifer B. Damico |
Principal Accounting Officer, Senior Vice President and Controller |
-- |
26/02/2026 |
| Ms. Payal Sahni |
Chief People Experience Officer and Executive Vice President |
-- |
26/02/2026 |
| Mr. Aamir Malik |
Chief U.S. Commercial Officer and Executive Vice President |
美元 1.39M |
26/02/2026 |
| Mr. Michael McDermott |
Executive Vice President, Chief Global Supply and Quality Officer |
-- |
26/02/2026 |
| Dr. Chris Boshoff, M.D.,PhD |
Chief Scientific Officer and President, Research and Development |
美元 1.40M |
26/02/2026 |
| Mr. Alexandre de Germay |
Chief International Commercial Officer and Executive Vice President |
-- |
26/02/2026 |
| Dr. Andrew Baum, M.D. |
Executive Vice President, Chief Strategy and Innovation Officer |
-- |
26/02/2026 |
| Ms. Cecile Guegan |
Senior Vice President, Finance, Global Biopharmaceutical Business |
-- |
18/06/2026 |
|
|
| Mr. Ronald E. Blaylock |
Independent Director |
12/03/2026 |
| Mr. Shantanu Narayen |
Lead Independent Director |
12/03/2026 |
| Ms. Suzanne Nora Johnson |
Independent Director |
12/03/2026 |
| Dr. Scott Gottlieb,M.D. |
Independent Director |
12/03/2026 |
| Mr. James Robert Quincey |
Independent Director |
12/03/2026 |
| Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H. |
Independent Director |
12/03/2026 |
| Mr. James C. Smith |
Independent Director |
12/03/2026 |
| Dr. Albert Bourla, D.V.M.,PhD |
Chairman of the Board and Chief Executive Officer |
12/03/2026 |
| Mr. Joseph J. Echevarria |
Independent Director |
12/03/2026 |
| Mr. Cyrus Taraporevala |
Independent Director |
12/03/2026 |
| Dr. Dan R. Littman, M.D.,PhD |
Independent Director |
12/03/2026 |
| Mr. Mortimer J. Buckley |
Independent Director |
12/03/2026 |
|
|
|
|
